Comparative analysis of the intestinal flora in type 2 diabetes and nondiabetic mice

Experimental Animals

Volumn 66, Issue 4, 2017, Pages 405-416

  Horie, Masanori ^a   Miura, Takamasa ^b   Hirakata, Satomi ^b   Hosoyama, Akira ^b   Sugino, Sakiko ^a   Umeno, Aya ^a   Murotomi, Kazutoshi ^a   Yoshida, Yasukazu ^a   Koike, Taisuke ^c  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b NATIONAL INSTITUTE OF TECHNOLOGY AND EVALUATION   (Japan)

^c MITSUBISHI CHEMICAL CORPORATION   (Japan)

Author keywords

Intestinal flora; Lactobacillus; TSOD mouse; Turicibacter; Type 2 diabetes

Indexed keywords

LIPID HYDROPEROXIDE; MACROPHAGE INFLAMMATORY PROTEIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL FLORA; BACTEROIDALES; BACTEROIDETES; BODY WEIGHT; CECUM; CLOSTRIDIACEAE; CLOSTRIDIALES; CONTROLLED STUDY; DATA ANALYSIS; DNA EXTRACTION; DNA LIBRARY; ENZYME LINKED IMMUNOSORBENT ASSAY; FATTY LIVER; FECES; FIRMICUTES; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INTESTINE FLORA; LACHNOSPIRACEAE; LACTOBACILLUS; LIVER DISEASE; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; POLYMERASE CHAIN REACTION; RUMINOCOCCUS; ANIMAL; COMPARATIVE STUDY; DISEASE MODEL; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MOUSE MUTANT;

ANIMALS; BACTEROIDETES; CECUM; CLOSTRIDIACEAE; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; FIRMICUTES; GASTROINTESTINAL MICROBIOME; LACTOBACILLUS; MALE; MICE, OBESE;

EID: 85032721614     PISSN: 13411357     EISSN: None     Source Type: Journal    
DOI: 10.1538/expanim.17-0021     Document Type: Article

References (47)

1. Allen, J.M., Berg Miller, M.E., Pence, B.D., Whitlock, K., Nehra, V., Gaskins, H.R., White, B.A., Fryer, J.D., and Woods, J.A. 2015. Voluntary and forced exercise differentially alters the gut microbiome in C57BL/6J mice. J. Appl. Physiol. 118: 1059–1066. [Medline] [CrossRef]
2. Aronesty, E.2011. ea-utils: Command-line tools for processing biological sequencing data; Available online at: http://code.google.com/p/ea-utils.
3. Benno, Y. 1990. Effect of diets on human fecal microflora. Bifidus 4: 1–12.
4. Bosshard, P.P., Zbinden, R., and Altwegg, M. 2002. Turicibacter sanguinis gen. nov., sp. nov., a novel anaerobic, Gram-positive bacterium. Int. J. Syst. Evol. Microbiol. 52: 1263–1266. [Medline]
5. Burcelin, R., Serino, M., Chabo, C., Blasco-Baque, V., and Amar, J. 2011. Gut microbiota and diabetes: from pathogenesis to therapeutic perspective. Acta Diabetol. 48: 257–273. [Medline] [CrossRef]
6. Caporaso, J.G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F.D., Costello, E.K., Fierer, N., Peña, A.G., Goodrich, J.K., Gordon, J.I., Huttley, G.A., Kelley, S.T., Knights, D., Koenig, J.E., Ley, R.E., Lozupone, C.A., Mc-Donald, D., Muegge, B.D., Pirrung, M., Reeder, J., Sevinsky, J.R., Turnbaugh, P.J., Walters, W.A., Widmann, J., Yatsunenko, T., Zaneveld, J., and Knight, R. 2010. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7: 335–336. [Medline] [CrossRef]
7. DeSantis, T.Z., Hugenholtz, P., Larsen, N., Rojas, M., Brodie, E.L., Keller, K., Huber, T., Dalevi, D., Hu, P., and Andersen, G.L. 2006. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl. Environ. Microbiol. 72: 5069–5072. [Medline] [CrossRef]
8. Edberg, F., Andersson, A.F., and Holmström, S.J. 2012. Bacterial community composition in the water column of a lake formed by a former uranium open pit mine. Microb. Ecol. 64: 870–880. [Medline] [CrossRef]
9. Edgar, R.C. 2010. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26: 2460–2461. [Medline] [CrossRef]
10. Haas, B.J., Gevers, D., Earl, A.M., Feldgarden, M., Ward, D.V., Giannoukos, G., Ciulla, D., Tabbaa, D., Highlander, S.K., Sodergren, E., Methé, B., DeSantis, T.Z., Petrosino, J.F., Knight, R., and Birren, B.W. 2011. Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome Res. 21: 494–504. [Medline] [CrossRef]
11. Hachinura, S. 2007. Immune-modulation by lactic acid bacteria. Nihon Nyusankin Gakkaishi 18: 54–57.
12. Herlemann, D.P., Labrenz, M., Jürgens, K., Bertilsson, S., Waniek, J.J., and Andersson, A.F. 2011. Transitions in bacterial communities along the 2000 km salinity gradient of the Baltic Sea. ISME J. 5: 1571–1579. [Medline] [CrossRef]
13. Hirayama, I., Yi, Z., Izumi, S., Arai, I., Suzuki, W., Nagamachi, Y., Kuwano, H., Takeuchi, T., and Izumi, T. 1999. Genetic analysis of obese diabetes in the TSOD mouse. Diabetes 48: 1183–1191. [Medline] [CrossRef]
14. Honda, K. and Littman, D.R. 2016. The microbiota in adaptive immune homeostasis and disease. Nature 535: 75–84. [Medline] [CrossRef]
15. Hsu, K.H., Pei, C., Yeh, J.Y., Shih, C.H., Chung, Y.C., Hung, L.T., and Ou, B.R. 2009. Production of bioactive human alpha-defensin 5 in Pichia pastoris. J. Gen. Appl. Microbiol. 55: 395–401. [Medline] [CrossRef]
16. Jung, M.J., Lee, J., Shin, N.R., Kim, M.S., Hyun, D.W., Yun, J.H., Kim, P.S., Whon, T.W., and Bae, J.W. 2016. Chronic Repression of mTOR Complex 2 Induces Changes in the Gut Microbiota of Diet-induced Obese Mice. Sci. Rep. 6: 30887. [Medline] [CrossRef]
17. Kataoka, K. 2016. The intestinal microbiota and its role in human health and disease. J. Med. Invest. 63: 27–37. [Medline] [CrossRef]
18. Kimoto-Nira, H., Aoki, R., Sasaki, K., Suzuki, C., and Mizumachi, K. 2012. Effect of oral intake of a Lactococcus lactis strain on skin properties of women -a Pilot Study-. Nihon Chikusan Gakkaiho 83: 307–313. [CrossRef]
19. Lau, E., Carvalho, D., Pina-Vaz, C., Barbosa, J.A., and Freitas, P. 2015. Beyond gut microbiota: understanding obesity and type 2 diabetes. Hormones (Athens) 14: 358–369. [Medline]
20. Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., Almeida, M., Arumugam, M., Batto, J.M., Kennedy, S., Leonard, P., Li, J., Burgdorf, K., Grarup, N., Jørgensen, T., Brandslund, I., Nielsen, H.B., Juncker, A.S., Bertalan, M., Levenez, F., Pons, N., Rasmussen, S., Sunagawa, S., Tap, J., Tims, S., Zoetendal, E.G., Brunak, S., Clément, K., Doré, J., Kleerebezem, M., Kristiansen, K., Renault, P., Sicheritz-Ponten, T., de Vos, W.M., Zucker, J.D., Raes, J., Hansen, T., Bork, P., Wang, J., Ehrlich, S.D., and Pedersen, O. 2013. Richness of human gut microbiome correlates with metabolic markers. Nature 500: 541–546. [Medline] [CrossRef]
21. Lozupone, C. and Knight, R. 2005. UniFrac: a new phylogenetic method for comparing microbial communities. Appl. Environ. Microbiol. 71: 8228–8235. [Medline] [CrossRef]
22. Mathew, B. and Nagaraj, R. 2015. Antimicrobial activity of human α-defensin 5 and its linear analogs: N-terminal fatty acylation results in enhanced antimicrobial activity of the linear analogs. Peptides 71: 128–140. [Medline] [CrossRef]
23. Messaoudi, S., Madi, A., Prévost, H., Feuilloley, M., Manai, M., Dousset, X., and Connil, N. 2012. In vitro evaluation of the probiotic potential of Lactobacillus salivarius SMXD51. Anaerobe 18: 584–589. [Medline] [CrossRef]
24. Mitsuoka, T. 1982. Role of intestinal flora in human health. Eisei Kagaku 28: 43–59. [CrossRef]
25. Mobini, R., Tremaroli, V., Ståhlman, M., Karlsson, F., Levin, M., Ljungberg, M., Sohlin, M., Bertéus Forslund, H., Perkins, R., Bäckhed, F., and Jansson, P.A. 2017. Metabolic effects of Lactobacillus reuteri DSM 17938 in people with type 2 diabetes: A randomized controlled trial. Diabetes Obes. Metab. 19: 579–589. [Medline] [CrossRef]
26. Morishita, Y. 1998. Dietary components responsible for the stability and alteration of the intestinal microflora (1). Chonai Saikingaku Zasshi 12: 1–12.
27. Murotomi, K., Umeno, A., Yasunaga, M., Shichiri, M., Ishida, N., Abe, H., Yoshida, Y., and Nakajima, Y. 2014. Type 2 diabetes model TSOD mouse is exposed to oxidative stress at young age. J. Clin. Biochem. Nutr. 55: 216–220. [Medline] [CrossRef]
28. Murotomi, K., Umeno, A., Yasunaga, M., Shichiri, M., Ishida, N., Abe, H., Yoshida, Y., and Nakajima, Y. 2015. Switching from singlet-oxygen-mediated oxidation to free-radicalmediated oxidation in the pathogenesis of type 2 diabetes in model mouse. Free Radic. Res. 49: 133–138. [Medline] [CrossRef]
29. Setchell, K.D., Brown, N.M., and Lydeking-Olsen, E. 2002. The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J. Nutr. 132: 3577–3584. [Medline]
30. Pedersen, H.K., Gudmundsdottir, V., Nielsen, H.B., Hyotylainen, T., Nielsen, T., Jensen, B.A., Forslund, K., Hildebrand, F., Prifti, E., Falony, G., Le Chatelier, E., Levenez, F., Doré, J., Mattila, I., Plichta, D.R., Pöhö, P., Hellgren, L.I., Arumugam, M., Sunagawa, S., Vieira-Silva, S., Jørgensen, T., Holm, J.B., Trošt, K., Kristiansen, K., Brix, S., Raes, J., Wang, J., Hansen, T., Bork, P., Brunak, S., Oresic, M., Ehrlich, S.D., and Pedersen, O. 2016. Human gut microbes impact host serum metabolome and insulin sensitivity. Nature 535: 376–381. [Medline] [CrossRef]
31. Pope, J.L., Tomkovich, S., Yang, Y., and Jobin, C. 2017. Microbiota as a mediator of cancer progression and therapy. Transl. Res. 179: 139–154. [Medline]
32. Sato, J., Kanazawa, A., Ikeda, F., Yoshihara, T., Goto, H., Abe, H., Komiya, K., Kawaguchi, M., Shimizu, T., Ogihara, T., Tamura, Y., Sakurai, Y., Yamamoto, R., Mita, T., Fujitani, Y., Fukuda, H., Nomoto, K., Takahashi, T., Asahara, T., Hirose, T., Nagata, S., Yamashiro, Y., and Watada, H. 2014. Gut dysbiosis and detection of “live gut bacteria” in blood of Japanese patients with type 2 diabetes. Diabetes Care 37: 2343–2350. [Medline] [CrossRef]
33. Schroeder, B.O., Ehmann, D., Precht, J.C., Castillo, P.A., Küchler, R., Berger, J., Schaller, M., Stange, E.F., and Wehkamp, J. 2015. Paneth cell α-defensin 6 (HD-6) is an antimicrobial peptide. Mucosal Immunol. 8: 661–671. [Medline] [CrossRef]
34. Stahel, P., Kim, J.J., Xiao, C., and Cant, J.P. 2017. Of the milk sugars, galactose, but not prebiotic galacto-oligosaccharide, improves insulin sensitivity in male Sprague-Dawley rats. PLoS One 12: e0172260. [Medline] [CrossRef]
35. Sun, Y., Su, Y., and Zhu, W. 2016. Microbiome-Metabolome Responses in the Cecum and Colon of Pig to a High Resistant Starch Diet. Front. Microbiol. 7: 779. [Medline] [Cross- Ref]
36. Suzuki, W., Iizuka, S., Tabuchi, M., Funo, S., Yanagisawa, T., Kimura, M., Sato, T., Endo, T., and Kawamura, H. 1999. A new mouse model of spontaneous diabetes derived from ddY strain. Exp. Anim. 48: 181–189. [Medline] [CrossRef]
37. Turnbaugh, P.J., Hamady, M., Yatsunenko, T., Cantarel, B.L., Duncan, A., Ley, R.E., Sogin, M.L., Jones, W.J., Roe, B.A., Affourtit, J.P., Egholm, M., Henrissat, B., Heath, A.C., Knight, R., and Gordon, J.I. 2009. A core gut microbiome in obese and lean twins. Nature 457: 480–484. [Medline] [CrossRef]
38. U meno, A., Shichiri, M., Ishida, N., Hashimoto, Y., Abe, K., Kataoka, M., Yoshino, K., Hagihara, Y., Aki, N., Funaki, M., Asada, Y., and Yoshida, Y. 2013. Singlet oxygen induced products of linoleates, 10- and 12-(Z,E)-hydroxyoctadecadienoic acids (HODE), can be potential biomarkers for early detection of type 2 diabetes. PLoS One 8: e63542. [Medline] [CrossRef]
39. Unoki, H., Takahashi, A., Kawaguchi, T., Hara, K., Horikoshi, M., Andersen, G., Ng, D.P., Holmkvist, J., Borch-Johnsen, K., Jørgensen, T., Sandbaek, A., Lauritzen, T., Hansen, T., Nurbaya, S., Tsunoda, T., Kubo, M., Babazono, T., Hirose, H., Hayashi, M., Iwamoto, Y., Kashiwagi, A., Kaku, K., Kawamori, R., Tai, E.S., Pedersen, O., Kamatani, N., Kadowaki, T., Kikkawa, R., Nakamura, Y., and Maeda, S. 2008. SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. Nat. Genet. 40: 1098–1102. [Medline] [CrossRef]
40. Upadhyaya, S. and Banerjee, G. 2015. Type 2 diabetes and gut microbiome: at the intersection of known and unknown. Gut Microbes 6: 85–92. [Medline] [CrossRef]
41. Wang, Q., Garrity, G.M., Tiedje, J.M., and Cole, J.R. 2007. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl. Environ. Microbiol. 73: 5261–5267. [Medline] [CrossRef]
42. World Health Organization 2016. Global report on diabetes. WHO press.
43. Yassour, M., Lim, M.Y., Yun, H.S., Tickle, T.L., Sung, J., Song, Y.M., Lee, K., Franzosa, E.A., Morgan, X.C., Gevers, D., Lander, E.S., Xavier, R.J., Birren, B.W., Ko, G., and Huttenhower, C. 2016. Sub-clinical detection of gut microbial biomarkers of obesity and type 2 diabetes. Genome Med. 8: 17. [Medline] [CrossRef]
44. Yasuda, K., Miyake, K., Horikawa, Y., Hara, K., Osawa, H., Furuta, H., Hirota, Y., Mori, H., Jonsson, A., Sato, Y., Yamagata, K., Hinokio, Y., Wang, H.Y., Tanahashi, T., Nakamura, N., Oka, Y., Iwasaki, N., Iwamoto, Y., Yamada, Y., Seino, Y., Maegawa, H., Kashiwagi, A., Takeda, J., Maeda, E., Shin, H.D., Cho, Y.M., Park, K.S., Lee, H.K., Ng, M.C., Ma, R.C., So, W.Y., Chan, J.C., Lyssenko, V., Tuomi, T., Nilsson, P., Groop, L., Kamatani, N., Sekine, A., Nakamura, Y., Yamamoto, K., Yoshida, T., Tokunaga, K., Itakura, M., Makino, H., Nanjo, K., Kadowaki, T., and Kasuga, M. 2008. Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat. Genet. 40: 1092–1097. [Medline] [CrossRef]
45. Zapata, H.J. and Quagliarello, V.J. 2015. The microbiota and microbiome in aging: potential implications in health and age-related diseases. J. Am. Geriatr. Soc. 63: 776–781. [Medline] [CrossRef]
46. Zhao, C., Wang, I., and Lehrer, R.I. 1996. Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett. 396: 319–322. [Medline] [CrossRef]
47. Zhong, Y., Nyman, M., and Fåk, F. 2015. Modulation of gut microbiota in rats fed high-fat diets by processing wholegrain barley to barley malt. Mol. Nutr. Food Res. 59: 2066–2076. [Medline] [CrossRef]